Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | BMY | AMGN | GILD | MRNA |
| Company | Alexion Pharm Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 181.04 | 49.16 | 272.14 | 67.09 | 104.46 |
| High | 182.67 | 49.47 | 274.48 | 67.68 | 108.21 |
| Low | 180.13 | 48.96 | 271.05 | 67.00 | 103.48 |
| Last | 182.50 | 48.99 | 273.54 | 67.03 | 107.89 |
| Change | +3.05 | -0.15 | +1.63 | +0.08 | +3.43 |
| % Change | +1.70% | -0.31% | +0.60% | +0.12% | +3.28% |
| Volume | 90,506,096 | 9,153,200 | 2,493,300 | 5,240,200 | 2,435,200 |
| 20-Day Average Volume | 8,395,359 | 10,953,850 | 2,216,505 | 6,335,325 | 3,264,185 |
| Previous Close | 179.45 | 49.14 | 271.91 | 66.95 | 104.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 50.55 | 271.99 | 69.34 | 105.15 |
| 20-Day Raw Stochastic | 44.63% | 20.04% | 46.12% | 14.18% | 57.65% |
| 20-Day Relative Strength | 55.14% | 41.71% | 48.69% | 32.82% | 55.49% |
| Weighted Alpha | +62.81 | -25.74 | +11.45 | -20.86 | -9.49 |
| Today's Opinion | 72% Buy | 88% Sell | 40% Sell | 100% Sell | 88% Buy |
| Previous Opinion | 72% Buy | 88% Sell | 40% Sell | 100% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 8% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | +1.51% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | +3.95% since 04/16/24 |
| Low | 178.51 on 07/19/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 99.30 on 04/22/24 |
| High | 187.45 on 07/14/21 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 108.21 on 04/23/24 |
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | -5.66% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | +2.33% since 03/22/24 |
| Low | 178.51 on 07/19/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 97.00 on 04/03/24 |
| High | 187.45 on 07/14/21 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | -2.25% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | +5.86% since 01/23/24 |
| Low | 164.83 on 04/29/21 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 84.06 on 02/13/24 |
| High | 187.45 on 07/14/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | -12.52% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | +37.19% since 10/23/23 |
| Low | 146.97 on 03/04/21 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 62.55 on 11/02/23 |
| High | 187.45 on 07/14/21 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 99,594,944 | 145,845,984 | 83,357,904 | 39,995,644 |
| Shares Outstanding, K | 221,019 | 2,026,759 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 6,069,900,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | 603,400,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 1,636,500,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | 636,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 1.25 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 07/29/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 6.52 | 14.42 | 9.93 | 0.00 |